|
If the 20th century was the era of physics and nuclear fission, the 21st belongs to the life sciences. Moving from gene, to genome, to genetically based diseases, this program provides an overview of the interrelated fields of genomics, proteomics, and bioinformatics, with an emphasis on practical applications of biotechnology to the field of medicine. Are genetically personalized drugs around the next corner? Commentary is provided by Bob Forgey, of ProNAI Therapeutics; Bill Worzel and Jeanne Orhnberger, of Genetics Squared; and Drs. Brian Athey and Elliott Hill, of the University of Michigan.
|